Gingival displacement systems efficacy before impression : multicenter randomized clinical trial

Objectives: Quantitative assessment of gingival sulcus width (lateral displacement) obtained by three retraction systems (Racestyptine +Cord, Racegel + Cord and Racegel) in order to collect clinical performance and safety data from them (Retract study).

Methods: Design of the trial was prospective, multi-center randomized, controlled, open label, 3-arm parallel group. The primary endpoint was the lateral gingival displacement.
In this post-market clinical follow up study, both Racestyptine Solution and Racegel are investigational devices. No device was used as comparator, each gingival retraction system was compared to a reference value of minimal expected tissue displacement.

Results: The lateral gingival displacement obtained by Racestyptine with a retraction cord (253 ± 59 µm, p<0.0001) and by Racegel with a retraction cord (247 ± 61 µm, p=0.0007) were significantly higher than 200 µm. Lateral displacement obtained with Racegel cordless was 207 ± 57 µm (p=0.53). Astringent effect of the three retractions systems was confirmed by the absence of crevicular fluid reported on more than 96% of the patients and by bleeding observed on 7 cases. No peri-odondal damage was observed immediately and 7 days after retraction. Prosthesis fits correctly on the prepared tooth for all patients of the 3 groups.

Conclusions: RETRACT Study shows that Racestyptine and Racegel provides a sufficient sulcus opening prior impression taking in restorative dentistry.


Authors: (FIRST NAME, LAST NAME): HUGUES COLOMBEL1, MARIE-JOSEPH DAUTEL1, FRANCOISE BASLE1, JACQUES RUBIN1, DOMINIQUE BASLE1, HUGO ABGRALL1, FRANCK DELANOUE1, VINCENT BAR1, MARIE THEVENIAU2, ANNE DAUTEL3


INSTITUTIONS (ALL): 1. Dentistry, Private, RENNES, BRETAGNE, France.
2. Centre de Soins Dentaires du CHU de Rennes Faculté d’Odontologie, CHU Rennes Université de Rennes 1, RENNES, BRETAGNE, France.
3. Centre de Soins Dentaires du CHU de Rennes Faculté d’Odontologie – Université de Rennes 1, CHU RENNES, RENNES, BRETAGNE, France.

SLB Pharma est une société prestataire de services en recherche clinique bénéficiant de l’agrément Crédit Impôt Recherche.

SLB Pharma est une société prestataire de services en recherche clinique bénéficiant de l’agrément Crédit Impôt Recherche.